BAROLE

This brand name is authorized in Nigeria.

Active ingredients

The drug BAROLE contains one active pharmaceutical ingredient (API):

1	Rabeprazole UNII 3L36P16U4R - RABEPRAZOLE SODIUM
	Rabeprazole belongs to the class of anti-secretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonist properties, but suppress gastric acid secretion by the specific inhibition of the H+/K+ -ATPase enzyme (the acid or proton pump).
	Read more about Rabeprazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-5749	Injection	BAROLE I.V. INJECTION INJ 20 mg I X 1 transparent glass vial	93 RNW-PP-261647 BAROLE I.V. INJECTION RABEPRAZOLE SODIUM 20MG RABEPRAZOLE SODIUM 20MG, MANNITOL, SODIUM CARBONATE, SODIUM HYDROXIDE, WATER FOR INJECTION A4-5749 Drugs ALIMENTARY TRACT AND METABOLISM Imported Products I1 transparent glass vial Prescription Only Medicine (POM) 4/21/2022 MEGA LIFESCIENCES NIGERIA LIMITED, GUINNESS ROAD, OGBA - IKEJA OGBA LAGOS 8053596201 info.ng@megawecare.com GUFIC BIOSCIENCES LIMITED, N.H NO. 8, NEAR GRID, KABILPORE, NAVSARI, GUJARAT, INDIA, India	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BC04	Rabeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-5749